Drug Development Consulting Holding ApS — Credit Rating and Financial Key Figures
CVR number: 42285722
Smedeland 36, Smedeland 2600 Glostrup
Income statement (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | 83 872.00 | 154 321.00 | 141 604.00 |
| Employee benefit expenses | -82 581.00 | - 144 843.66 | - 134 352.43 |
| Total depreciation | -14 764.00 | -17 139.00 | -16 445.97 |
| EBIT | -13 473.00 | -7 661.66 | -9 194.40 |
| Other financial income | 509.36 | 921.35 | |
| Other financial expenses | -2 271.00 | -4 006.00 | -4 667.29 |
| Pre-tax profit | -15 744.00 | -11 158.30 | -12 940.33 |
| Income taxes | 32.00 | - 716.00 | 3 564.00 |
| Net earnings | -15 712.00 | -11 874.30 | -9 376.33 |
Assets (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Development expenditure | 2 643.00 | 2 897.00 | 6 796.00 |
| Intangible rights | 45 170.00 | 38 301.38 | 32 230.38 |
| Goodwill | 71 254.00 | 63 648.52 | 56 043.52 |
| Intangible assets total | 119 067.00 | 104 846.90 | 95 069.90 |
| Buildings | 4 997.00 | 4 042.00 | 4 798.00 |
| Machinery and equipment | 1 702.00 | 1 549.33 | 1 844.82 |
| Tangible assets total | 6 699.00 | 5 591.33 | 6 642.82 |
| Other non-current investments | 0.01 | ||
| Investments total | 2 243.00 | 2 294.77 | 2 503.28 |
| Long term receivables total | |||
| Inventories total | |||
| Current trade debtors | 55 408.00 | 39 551.00 | 38 210.00 |
| Prepayments and accrued income | 10 011.00 | 3 013.00 | 2 718.00 |
| Current other receivables | 1 514.00 | 8 684.00 | 12 318.00 |
| Short term receivables total | 66 933.00 | 51 248.00 | 53 246.00 |
| Cash and bank deposits | 70 162.00 | 49 638.00 | 25 516.00 |
| Cash and cash equivalents | 70 162.00 | 49 638.00 | 25 516.00 |
| Balance sheet total (assets) | 265 104.00 | 213 619.00 | 182 978.00 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Share capital | 200.00 | 228.00 | 245.00 |
| Share premium account | 86 321.00 | 99 293.00 | 107 163.00 |
| Retained earnings | -15 659.00 | -27 571.30 | |
| Profit of the financial year | -15 712.00 | -11 874.30 | -9 376.33 |
| Shareholders equity total | 70 809.00 | 71 987.70 | 70 460.37 |
| Provisions | 10 527.00 | 0.30 | -0.37 |
| Non-current loans from credit institutions | 102 060.00 | 48 310.00 | 45 590.00 |
| Non-current accruals and deferred income | 9 111.00 | 5 546.00 | |
| Non-current other liabilities | -51 030.00 | 6 175.00 | 6 181.00 |
| Non-current deferred tax liabilities | 19 232.00 | ||
| Non-current liabilities total | 70 262.00 | 63 596.00 | 57 317.00 |
| Current loans from credit institutions | 15 442.00 | 2 720.00 | 2 720.00 |
| Advances received | 78 401.00 | 26 135.00 | 6 439.00 |
| Current trade creditors | 11 525.00 | 33 841.00 | 25 462.00 |
| Short-term deferred tax liabilities | 3 128.00 | 2 186.00 | |
| Other non-interest bearing current liabilities | 15 537.00 | 13 153.00 | 20 580.00 |
| Current liabilities total | 124 033.00 | 78 035.00 | 55 201.00 |
| Balance sheet total (liabilities) | 275 631.00 | 213 619.00 | 182 978.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.